Is ethanol-induced bronchospasm an inflammation-driven event?
Antonicelli
L
L
UO Allergologia, Dipartimento di Medicina Interna, Malattie Immuno-Allergiche e Respiratorie, Ospedale Regionale, Ancona, Italy. l.antonicelli@ao-umbertoprimo.marche.it
Micucci
C
C
Bonifazi
F
F
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D000335:Aerosol Propellants / Q000009:adverse effects* / Q000737:chemistry; D000730:Androstadienes / Q000008:administration & dosage; D018926:Anti-Allergic Agents / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy; D001507:Beclomethasone / Q000627:therapeutic use; D001985:Bronchial Provocation Tests; D001986:Bronchial Spasm / Q000139:chemically induced* / Q000276:immunology; D000431:Ethanol / Q000009:adverse effects*; D000068298:Fluticasone; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D012997:Solvents / Q000009:adverse effects*; D050916:TRPV Cation Channels / Q000187:drug effects / Q000378:metabolism
D000305:Adrenal Cortex Hormones; D000335:Aerosol Propellants; D000730:Androstadienes; D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents; D012997:Solvents; D050916:TRPV Cation Channels; C494484:TRPV1 receptor; D000431:Ethanol; D000068298:Fluticasone; D001507:Beclomethasone